Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Research Protocols

Date Submitted: Jul 3, 2026
Open Peer Review Period: Jul 9, 2026 - Sep 3, 2026
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Regulating Generative AI in Healthcare: Protocol for a Scoping Review

  • Mariha Ashraf; 
  • MaĆ«lle-Marie Corso; 
  • Camilla Fleetcroft; 
  • Vaishnavi Menon; 
  • Bilal Mateen; 
  • Alastair Denniston; 
  • Jeffry Hogg

ABSTRACT

Background:

Generative Artificial Intelligence (GenAI) is rapidly becoming an integral part of healthcare provision on a global scale. However, its unprecedented nature and fast paced transformation raises concerns around patient safety. With the global surge in health AI tools being developed and used, there is an urgent call on tighter and more robust regulatory oversight.

Objective:

We will conduct a scoping review to map and synthesise the current regulatory considerations of GenAI in healthcare. We will identify innovative approaches to regulating GenAI in health and characterise emerging challenges that regulators face, with the aim of supporting a needs-led approach to regulatory innovation.

Methods:

The proposed scoping review will be conducted in accordance with the JBI methodology for scoping reviews and follow the PRISMA-ScR reporting guidance. We will conduct a focussed regulatory website review complimented with a grey literature search using custom Google search and an academic literature search through Ovid Medline.

Results:

Preliminary searches and search strategy were conducted and refined in April 2026. The search strategy was executed in May 2026 with formal screening due to commence in June 2026. The final results are aimed to be submitted by November 2026.

Conclusions:

This review aims to provide an overview of the regulatory interventions currently being used in GenAI across the world, with the hope our findings will be able to inform regulators in the future.


 Citation

Please cite as:

Ashraf M, Corso MM, Fleetcroft C, Menon V, Mateen B, Denniston A, Hogg J

Regulating Generative AI in Healthcare: Protocol for a Scoping Review

JMIR Preprints. 03/07/2026:106167

DOI: 10.2196/preprints.106167

URL: https://preprints.jmir.org/preprint/106167

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.